Cargando…
Pediatric tuberculosis-human immunodeficiency virus co-infection in the United Kingdom highlights the need for better therapy monitoring tools: a case report
BACKGROUND: Tuberculosis is an infection that requires at least 6 months of chemotherapy in order to clear the bacteria from the patient’s lungs. Usually, therapeutic monitoring is dependent on smear microscopy where a decline in acid-fast bacilli is observed. However, this might not be indicative o...
Autores principales: | Evangelopoulos, Dimitrios, Whittaker, Elizabeth, Honeyborne, Isobella, McHugh, Timothy D., Klein, Nigel, Shingadia, Delane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5326674/ https://www.ncbi.nlm.nih.gov/pubmed/28236807 http://dx.doi.org/10.1186/s13256-017-1222-6 |
Ejemplares similares
-
Culture-Free Enumeration of Mycobacterium tuberculosis in Mouse Tissues Using the Molecular Bacterial Load Assay for Preclinical Drug Development
por: Evangelopoulos, Dimitrios, et al.
Publicado: (2022) -
Epidemiology and disease burden of tuberculosis in children: a global perspective
por: Seddon, James A, et al.
Publicado: (2014) -
Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy
por: Honeyborne, Isobella, et al.
Publicado: (2016) -
Pre-Clinical Tools for Predicting Drug Efficacy in Treatment of Tuberculosis
por: Margaryan, Hasmik, et al.
Publicado: (2022) -
Increased outbreaks of monkeypox highlight gaps in actual disease burden in Sub-Saharan Africa and in animal reservoirs
por: Haider, Najmul, et al.
Publicado: (2022)